02/13/2025
1:14 PM | Capital Research Global Investors (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
9:52 AM | BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
7:03 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:23 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:24 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:25 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:26 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
7:01 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:03 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:06 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:08 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for DNLI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Denali Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/07/2025
7:10 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:12 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
7:14 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/07/2025
5:56 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:57 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:59 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:17 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/31/2024
3:18 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:44 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
4:19 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
8:55 AM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2024
9:52 AM | Denali Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/07/2024
3:39 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:30 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Denali Therapeutics (Subject)
| Form SC 13G/A | |
10/18/2024
3:19 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
3:37 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:25 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:25 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
5:26 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Ho Carole (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:14 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:15 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:16 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
3:40 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:42 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:08 PM | Denali Therapeutics (Subject)
Watts Ryan J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
7:09 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Do this Before Elon’s Reveal on March 17th (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
08/20/2024
3:27 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024
12:18 PM | Denali Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G | |
08/15/2024
3:10 PM | Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
7:36 PM | Denali Therapeutics (Subject)
Ho Carole (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:37 PM | Denali Therapeutics (Subject)
Schuth Alexander O. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
5:52 AM | Denali Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024
5:48 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2024
8:13 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
8:13 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
3:38 PM | Denali Therapeutics (Subject)
Krognes Steve E. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2024
3:43 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
7:06 PM | Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:31 PM | Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:32 PM | Denali Therapeutics (Issuer)
Thornberry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:33 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:20 PM | Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:27 PM | Denali Therapeutics (Issuer)
Harris Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:28 PM | Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:29 PM | Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:30 PM | Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
5:30 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
3:01 PM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
4:14 PM | Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
3:32 PM | Denali Therapeutics (Subject)
SATO VICKI L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
5:07 PM | Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:59 PM | Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
3:01 PM | Denali Therapeutics (Filer)
| Form S-3ASR | |
03/01/2024
3:51 PM | Denali Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/27/2024
7:03 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
7:07 AM | Denali Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
